North Central London Training Hub homepage

Event Recap: Identify and Manage Chronic Kidney Disease to Save Lives: key updates to the NCL CKD Pathway Webinar

One year on from expanding the CKD Management Pathway across all boroughs of NCL, what insights have we gained? Which individuals with CKD benefit from SGLT-2 inhibitors (flozins)? What should I do if someone's potassium rises on an ACEi or ARB? What is Finerenone and what is its role in the management of diabetic kidney disease?

Watch back on our panel of experts to learn about key updates to the NCL CKD Pathway in 2025, which reflect new guidance for these medications that will increase the number of people who can benefit from the reduction in CVD mortality, and progression to dialysis. This webinar concluded with a Q&A session, where attendees were able to ask questions directly to the experts.

Panel members:

  • Sarah Milne Kidney Nurse Consultant, CKD Lead RFL and co-chair NCL CKD Steering Group

  • Sarah Morgan, GP CKD lead for NCL, and co-chair NCL CKD Steering Group

  • Dr Mark Jesky, Consultant Nephrologist and Clinical Lead for Renal Services

  • Sinead Burke, Lead CKD Dietitian 

Useful resources:

CKD Integrated Service page for clinicians, including how and who to refer to the service, the CKD pathway and further training opportunities:

CKD for patients, including leaflets and links to free monthly webinars for people living in NCL: